Is AACR up or down today?
AACR is down 1.15% today, last at 163.08. This stock moved -1.15% versus the prior close.
AACR · AACR
AACR (AACR) is trading at 163.08, down 1.15% on the session. AACR sits at the 50% mark of its 52-week range.
Leading the coverage: “Avacta Therapeutics (AIM: AVCT) Avacta data AACR underline AVA6103 profile - Share Talk” (Google News Company, 138d ago). AACR is +6.12% since story.
AACR trades on a trailing P/E of 41.4.
Analyst firms are mostly reiterating — no strong directional shift lately.
AACR is down 1.15% today, last at 163.08. This stock moved -1.15% versus the prior close.
Leading the coverage: “Avacta Therapeutics (AIM: AVCT) Avacta data AACR underline AVA6103 profile - Share Talk” (Google News Company, 138d ago). AACR is +6.12% since story. Dominant story: SLS Stock Sparks Retail Buzz Ahead of AACR Presentation On Experimental Cancer Therapy - Stocktwits (1 source, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
SLS Stock Sparks Retail Buzz Ahead of AACR Presentation On Experimental Cancer Therapy - Stocktwits
SELLAS Life Sciences Group (SLS) Lands 3 AACR Abstracts For SLS009 Pancreatic Cancer Data - Yahoo Finance
BeyondSpring Reports ASCO 2026 and AACR 2026 Plinabulin Data, Progress on DUBLIN-4 NSCLC Program, and Leadership Transition - Quiver Quantitative
Akari Therapeutics appoints former AACR President to Scientific Advisory Board - scanx.trade
IMUNON presents ovarian cancer therapy data at AACR conference - Investing.com